About Dr. Bray

Dr. Bray is a scientist-clinician with a clinical interest in bleeding and clotting disorders, and a research

interest in platelet and megakaryocyte biology.  After a Hematology-Oncology fellowship at the University of California, San Francisco, he spent 10 years on the faculty at Johns Hopkins University. In 2000, he became the first Chief of a new Section of Thrombosis Research at Baylor College of Medicine in Houston. In 2006 Dr. Bray became the 6th Director of the Cardeza Foundation for Hematologic Research and Director of Hematology at Thomas Jefferson University.

In late 2016, Dr. Bray joined the Division of Hematology and Hematologic Malignancies and the Molecular Medicine Program at the University of Utah as a Professor in the Department of Internal Medicine. Dr. Bray has served in numerous national and international advisory positions, NIH review panels and committees for the American Society of Hematology and the International Society of Thrombosis and Haemostasis.  He was an Investigator in the Women’s Health Initiative from 2000-2008 and charter member and co-Chair of the ISTH Scientific Subcommittee Genomics in Thrombosis and Hemostasis.  He has trained more than 30 postdoctoral fellows, graduate students, Hem/Onc fellows and junior faculty.

Dr. Bray has more than 30 years of continuous funding from the National Institutes of Health (NIH) and currently is PI on two NIH R01 grants and co-Investigator on others.  He has published more than 180 peer-reviewed papers, book chapters and invited reviews.

Research Interests: platelet and megakaryocyte biology, genomics and transcriptomics, pharmacogenetics, microRNAs, racial differences in ischemic vascular disease